Funding Opportunities in HIV/AIDS and HIV Malignancy Research
Notice of Availability of Administrative Supplements for U.S. - China Biomedical Collaborative Research on Cancer, Allergy, Immunology, and Infectious Diseases including HIV/AIDS and its Co-morbidities
Research on Malignancies in the Context of HIV/AIDS
Biomarkers of Infection-Associated Cancers
Centers for AIDS Research (CFARs)
Notice of Availability of Administrative Supplements for U.S. - Russia Collaborative HIV/AIDS Research
Notice of Availability of Administrative Supplements for U.S. - China Biomedical Collaborative Research on Cancer, Allergy, Immunology, and Infectious Diseases including HIV/AIDS and its Co-morbidities
The intent of this initiative is to foster, stimulate, and/or expand collaborative basic, translational, and applied research between eligible NIH grantees and eligible Chinese researchers in the areas of cancer, allergy, immunology, and infectious diseases including HIV/AIDS and its co-morbidities.
This initiative provides an opportunity for eligible NIH grantees to request administrative supplement support for their eligible active grants to enhance ongoing research efforts through collaborations with Chinese scientists under the new U.S.-China Program for Biomedical Research Cooperation. Based on the merit of the requests received and the availability of funds, the NIH may award up to $3,000,000 (total costs) in FY2011 for this effort, and the NSFC has pledged to provide complementary funding to support the Chinese co-investigators involved in the research collaborations.
Additional information:Research on Malignancies in the Context of HIV/AIDS
The purpose of this initiative is to stimulate research that will improve our understanding of molecular underpinnings in the development and progression of cancer in the context of HIV infection and AIDS.
Additional information:- PA-10-291, Research on Malignancies in the Context of HIV/AID (R21)
- PA-10-290, Research on Malignancies in the Context of HIV/AIDS (R01)
Biomarkers of Infection-Associated Cancers
This initiative is designed to foster research to increase our knowledge of infectious agent-associated malignancies and identify those who are at increased risk of developing cancer among infected individuals and to detect early stage cancers in this population. Research projects proposed in the applications may involve a number of infectious agents showing associations with cancer. Noteworthy viral agents of interest to this program are human papillomavirus (HPV), Hepatitis B and C viruses, Epstein-Barr virus (EBV), and Simian Virus 40. Furthermore, an escalating prevalence of early cervical, lung, and colon cancers has emerged among HIV patients.
Additional information:- PA-11-158, Biomarkers of Infection-Associated Cancers (R01)
- PA-11-159, Biomarkers of Infection-Associated Cancers (R21)
Centers for AIDS Research (CFARs)
The CFAR program provides administrative and shared research support to synergistically enhance and coordinate high quality AIDS research projects. CFARs accomplish this through core facilities that provide expertise, resources, and services not otherwise readily obtained through more traditional funding mechanisms. CFARs improve the institutions’ ability to carry multidisciplinary AIDS research and provide unique flexibility to respond to evolving scientific needs in AIDS research.
Additional information:Notice of Availability of Administrative Supplements for U.S. - Russia Collaborative HIV/AIDS Research
The National Institutes of Health (NIH) supports international collaborative research and research training on HIV/AIDS and the exchange of scientific information by HIV/AIDS researchers around the world. Scientific cooperation during the global HIV/AIDS pandemic has been strengthened between the United States (U.S.) and Russia. Further cooperative research and capacity-building focused on HIV/AIDS would be of mutual benefit to the U.S. and Russia. Therefore, the U.S. Secretary of Health and Human Services (HHS) supports the efforts of the NIH and the Russian Foundation for Basic Research (RFBR), to advance a new extramural research initiative.
Additional information: